Molecular DiagnosticsPoint of Care Market Size, Share 2023

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnostics in Point of Care Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnostics in Point of Care Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnostics in Point of Care Overall Market Size
2.1 Global Molecular Diagnostics in Point of Care Market Size: 2022 VS 2030
2.2 Global Molecular Diagnostics in Point of Care Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnostics in Point of Care Players in Global Market
3.2 Top Global Molecular Diagnostics in Point of Care Companies Ranked by Revenue
3.3 Global Molecular Diagnostics in Point of Care Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnostics in Point of Care Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Diagnostics in Point of Care Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnostics in Point of Care Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Molecular Diagnostics in Point of Care Market Size Markets, 2022 & 2030
4.1.2 Polymerase Chain Reaction
4.1.3 In Situ Hybridization
4.1.4 Gene Chips
4.1.5 Next Generation Sequencing
4.2 By Type - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnostics in Point of Care Revenue, 2018-2023
4.2.2 By Type - Global Molecular Diagnostics in Point of Care Revenue, 2023-2030
4.2.3 By Type - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnostics in Point of Care Market Size, 2022 & 2030
5.1.2 Hospitals and Clinics
5.1.3 Independent Clinical Laboratories
5.2 By Application - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnostics in Point of Care Revenue, 2018-2023
5.2.2 By Application - Global Molecular Diagnostics in Point of Care Revenue, 2023-2030
5.2.3 By Application - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Molecular Diagnostics in Point of Care Market Size, 2022 & 2030
6.2 By Region - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnostics in Point of Care Revenue, 2018-2023
6.2.2 By Region - Global Molecular Diagnostics in Point of Care Revenue, 2023-2030
6.2.3 By Region - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Molecular Diagnostics in Point of Care Revenue, 2018-2030
6.3.2 US Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.3.3 Canada Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.3.4 Mexico Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnostics in Point of Care Revenue, 2018-2030
6.4.2 Germany Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4.3 France Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4.4 U.K. Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4.5 Italy Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4.6 Russia Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4.7 Nordic Countries Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.4.8 Benelux Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnostics in Point of Care Revenue, 2018-2030
6.5.2 China Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.5.3 Japan Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.5.4 South Korea Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.5.5 Southeast Asia Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.5.6 India Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Molecular Diagnostics in Point of Care Revenue, 2018-2030
6.6.2 Brazil Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.6.3 Argentina Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue, 2018-2030
6.7.2 Turkey Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.7.3 Israel Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.7.4 Saudi Arabia Molecular Diagnostics in Point of Care Market Size, 2018-2030
6.7.5 UAE Molecular Diagnostics in Point of Care Market Size, 2018-2030
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Molecular Diagnostics in Point of Care Major Product Offerings
7.1.4 Abbott Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News
7.2 Accelerate Diagnostics
7.2.1 Accelerate Diagnostics Corporate Summary
7.2.2 Accelerate Diagnostics Business Overview
7.2.3 Accelerate Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.2.4 Accelerate Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.2.5 Accelerate Diagnostics Key News
7.3 Ador Diagnostics
7.3.1 Ador Diagnostics Corporate Summary
7.3.2 Ador Diagnostics Business Overview
7.3.3 Ador Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.3.4 Ador Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.3.5 Ador Diagnostics Key News
7.4 Beckman Coulter
7.4.1 Beckman Coulter Corporate Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Molecular Diagnostics in Point of Care Major Product Offerings
7.4.4 Beckman Coulter Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.4.5 Beckman Coulter Key News
7.5 Becton, Dickinson and Company
7.5.1 Becton, Dickinson and Company Corporate Summary
7.5.2 Becton, Dickinson and Company Business Overview
7.5.3 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Major Product Offerings
7.5.4 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.5.5 Becton, Dickinson and Company Key News
7.6 Binx Health
7.6.1 Binx Health Corporate Summary
7.6.2 Binx Health Business Overview
7.6.3 Binx Health Molecular Diagnostics in Point of Care Major Product Offerings
7.6.4 Binx Health Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.6.5 Binx Health Key News
7.7 Biocartis
7.7.1 Biocartis Corporate Summary
7.7.2 Biocartis Business Overview
7.7.3 Biocartis Molecular Diagnostics in Point of Care Major Product Offerings
7.7.4 Biocartis Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.7.5 Biocartis Key News
7.8 bioM?rieux
7.8.1 bioM?rieux Corporate Summary
7.8.2 bioM?rieux Business Overview
7.8.3 bioM?rieux Molecular Diagnostics in Point of Care Major Product Offerings
7.8.4 bioM?rieux Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.8.5 bioM?rieux Key News
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Corporate Summary
7.9.2 Bio-Rad Laboratories Business Overview
7.9.3 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Major Product Offerings
7.9.4 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.9.5 Bio-Rad Laboratories Key News
7.10 Bosch Healthcare Solutions
7.10.1 Bosch Healthcare Solutions Corporate Summary
7.10.2 Bosch Healthcare Solutions Business Overview
7.10.3 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Major Product Offerings
7.10.4 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.10.5 Bosch Healthcare Solutions Key News
7.11 Curetis
7.11.1 Curetis Corporate Summary
7.11.2 Curetis Business Overview
7.11.3 Curetis Molecular Diagnostics in Point of Care Major Product Offerings
7.11.4 Curetis Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.11.5 Curetis Key News
7.12 Eurofins Scientific
7.12.1 Eurofins Scientific Corporate Summary
7.12.2 Eurofins Scientific Business Overview
7.12.3 Eurofins Scientific Molecular Diagnostics in Point of Care Major Product Offerings
7.12.4 Eurofins Scientific Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.12.5 Eurofins Scientific Key News
7.13 Genetic Signatures
7.13.1 Genetic Signatures Corporate Summary
7.13.2 Genetic Signatures Business Overview
7.13.3 Genetic Signatures Molecular Diagnostics in Point of Care Major Product Offerings
7.13.4 Genetic Signatures Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.13.5 Genetic Signatures Key News
7.14 Grifols
7.14.1 Grifols Corporate Summary
7.14.2 Grifols Business Overview
7.14.3 Grifols Molecular Diagnostics in Point of Care Major Product Offerings
7.14.4 Grifols Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.14.5 Grifols Key News
7.15 Hibergene Diagnostics
7.15.1 Hibergene Diagnostics Corporate Summary
7.15.2 Hibergene Diagnostics Business Overview
7.15.3 Hibergene Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.15.4 Hibergene Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.15.5 Hibergene Diagnostics Key News
7.16 Lumos Diagnostics
7.16.1 Lumos Diagnostics Corporate Summary
7.16.2 Lumos Diagnostics Business Overview
7.16.3 Lumos Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.16.4 Lumos Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.16.5 Lumos Diagnostics Key News
7.17 Roche
7.17.1 Roche Corporate Summary
7.17.2 Roche Business Overview
7.17.3 Roche Molecular Diagnostics in Point of Care Major Product Offerings
7.17.4 Roche Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.17.5 Roche Key News
7.18 Siemens
7.18.1 Siemens Corporate Summary
7.18.2 Siemens Business Overview
7.18.3 Siemens Molecular Diagnostics in Point of Care Major Product Offerings
7.18.4 Siemens Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.18.5 Siemens Key News
7.19 Thermo Fisher Scientific
7.19.1 Thermo Fisher Scientific Corporate Summary
7.19.2 Thermo Fisher Scientific Business Overview
7.19.3 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Major Product Offerings
7.19.4 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.19.5 Thermo Fisher Scientific Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Molecular Diagnostics in Point of Care Market Opportunities & Trends in Global Market
Table 2. Molecular Diagnostics in Point of Care Market Drivers in Global Market
Table 3. Molecular Diagnostics in Point of Care Market Restraints in Global Market
Table 4. Key Players of Molecular Diagnostics in Point of Care in Global Market
Table 5. Top Molecular Diagnostics in Point of Care Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Molecular Diagnostics in Point of Care Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Molecular Diagnostics in Point of Care Revenue Share by Companies, 2018-2023
Table 8. Global Companies Molecular Diagnostics in Point of Care Product Type
Table 9. List of Global Tier 1 Molecular Diagnostics in Point of Care Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Molecular Diagnostics in Point of Care Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Molecular Diagnostics in Point of Care Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Molecular Diagnostics in Point of Care Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Molecular Diagnostics in Point of Care Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Molecular Diagnostics in Point of Care Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Molecular Diagnostics in Point of Care Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2023-2030
Table 30. Abbott Corporate Summary
Table 31. Abbott Molecular Diagnostics in Point of Care Product Offerings
Table 32. Abbott Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 33. Accelerate Diagnostics Corporate Summary
Table 34. Accelerate Diagnostics Molecular Diagnostics in Point of Care Product Offerings
Table 35. Accelerate Diagnostics Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 36. Ador Diagnostics Corporate Summary
Table 37. Ador Diagnostics Molecular Diagnostics in Point of Care Product Offerings
Table 38. Ador Diagnostics Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 39. Beckman Coulter Corporate Summary
Table 40. Beckman Coulter Molecular Diagnostics in Point of Care Product Offerings
Table 41. Beckman Coulter Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 42. Becton, Dickinson and Company Corporate Summary
Table 43. Becton, Dickinson and Company Molecular Diagnostics in Point of Care Product Offerings
Table 44. Becton, Dickinson and Company Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 45. Binx Health Corporate Summary
Table 46. Binx Health Molecular Diagnostics in Point of Care Product Offerings
Table 47. Binx Health Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 48. Biocartis Corporate Summary
Table 49. Biocartis Molecular Diagnostics in Point of Care Product Offerings
Table 50. Biocartis Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 51. bioM?rieux Corporate Summary
Table 52. bioM?rieux Molecular Diagnostics in Point of Care Product Offerings
Table 53. bioM?rieux Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 54. Bio-Rad Laboratories Corporate Summary
Table 55. Bio-Rad Laboratories Molecular Diagnostics in Point of Care Product Offerings
Table 56. Bio-Rad Laboratories Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 57. Bosch Healthcare Solutions Corporate Summary
Table 58. Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Product Offerings
Table 59. Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 60. Curetis Corporate Summary
Table 61. Curetis Molecular Diagnostics in Point of Care Product Offerings
Table 62. Curetis Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 63. Eurofins Scientific Corporate Summary
Table 64. Eurofins Scientific Molecular Diagnostics in Point of Care Product Offerings
Table 65. Eurofins Scientific Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 66. Genetic Signatures Corporate Summary
Table 67. Genetic Signatures Molecular Diagnostics in Point of Care Product Offerings
Table 68. Genetic Signatures Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 69. Grifols Corporate Summary
Table 70. Grifols Molecular Diagnostics in Point of Care Product Offerings
Table 71. Grifols Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 72. Hibergene Diagnostics Corporate Summary
Table 73. Hibergene Diagnostics Molecular Diagnostics in Point of Care Product Offerings
Table 74. Hibergene Diagnostics Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 75. Lumos Diagnostics Corporate Summary
Table 76. Lumos Diagnostics Molecular Diagnostics in Point of Care Product Offerings
Table 77. Lumos Diagnostics Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 78. Roche Corporate Summary
Table 79. Roche Molecular Diagnostics in Point of Care Product Offerings
Table 80. Roche Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 81. Siemens Corporate Summary
Table 82. Siemens Molecular Diagnostics in Point of Care Product Offerings
Table 83. Siemens Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
Table 84. Thermo Fisher Scientific Corporate Summary
Table 85. Thermo Fisher Scientific Molecular Diagnostics in Point of Care Product Offerings
Table 86. Thermo Fisher Scientific Molecular Diagnostics in Point of Care Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Molecular Diagnostics in Point of Care Segment by Type in 2022
Figure 2. Molecular Diagnostics in Point of Care Segment by Application in 2022
Figure 3. Global Molecular Diagnostics in Point of Care Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Molecular Diagnostics in Point of Care Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Molecular Diagnostics in Point of Care Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Diagnostics in Point of Care Revenue in 2022
Figure 8. By Type - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
Figure 9. By Application - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
Figure 10. By Region - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
Figure 11. By Country - North America Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
Figure 12. US Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
Figure 16. Germany Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 17. France Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
Figure 24. China Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 28. India Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
Figure 30. Brazil Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2030
Figure 33. Turkey Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2018-2030
Figure 37. Abbott Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Accelerate Diagnostics Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Ador Diagnostics Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Beckman Coulter Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Becton, Dickinson and Company Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Binx Health Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Biocartis Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. bioM?rieux Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bio-Rad Laboratories Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Curetis Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eurofins Scientific Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Genetic Signatures Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Grifols Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Hibergene Diagnostics Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Lumos Diagnostics Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Roche Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Siemens Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Thermo Fisher Scientific Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

DOWNLOAD SAMPLE